InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by McClung David Mark, EVP, directeur commercial et COO. Director active across 1 companies, notably Sangamo Therapeutics, INC. Aggregated, 4 filings have been published. The latest transaction was filed on 25 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€47,21711,525 shares@ €4.09690.032% mcap15.5% of flow
Common Stock
SEC:0001209191-22-039649:0·
€24,3054,610 shares@ €5.27220.017% mcap8.0% of flow
Common Stock
SEC:0001209191-22-014167:0·
€116,11611,525 shares@ €10.0752100.0% of flow
Common Stock
SEC:0001209191-21-043811·
€116,11611,525 shares@ €10.07520.079% mcap38.2% of flow
Common Stock
SEC:0001209191-21-043811:0·
4 of 4 declarations
About McClung David Mark
David Mark McClung is the EVP, Chief Business Officer, and COO at SANGAMO THERAPEUTICS, INC. He oversees the operations and business initiatives of the company.
